Eris Formulations Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 2.00 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2015
About Eris Formulations
Eris Formulations Private Limited (EFPL) is Strike Off company established on 20 Apr 2012 with its office registered at Ahmedabad, Gujarat, India and has been running since 12 Year, 10 Months with a paid up capital of 2.00 M. According to MCA records, 2 Directors are linked to this company as of 30 Jan 2025.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239GJ2012PTC069999
- Company No.
069999
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2012
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Chemicals
Who are the key members and board of directors at Eris Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Bakshi  | Director | 20-Apr-2012 | Current |
| Himanshu Shah | Director | 20-Apr-2012 | Current |
Financial Performance of Eris Formulations.
Enhance accessibility to Eris Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Eris Formulations?
In 2015, Eris Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eris M. J. Biopharm Private LimitedAmit Bakshi is a mutual person
Eris Oaknet Healthcare Private LimitedAmit Bakshi is a mutual person
Eris Lifesciences LimitedAmit Bakshi is a mutual person
Amit Bakshi FoundationAmit Bakshi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eris Formulations?
Unlock and access historical data on people associated with Eris Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eris Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Eris Formulations
Recent activity within the organization
- Annual General Meeting
Eris Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records.
- Balance Sheet
Eris Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Ahmedabad.
- Director Appointment
Amit Indubhushan Bakshi was appointed as a Director was appointed as a Director on 20 Apr 2012 & has been associated with this company since 12 years 10 months .
- Director Appointment
Himanshu Jayantbhai Shah was appointed as a Director was appointed as a Director on 20 Apr 2012 & has been associated with this company since 12 years 10 months .
- Company Incorporation
Eris Formulations Private Limited was registered on 20 Apr 2012 with Roc Ahmedabad & aged 12 years 10 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Eris Formulations Private Limited?
Eris Formulations Private Limited was incorporated on 20 Apr 2012.
What is authorized share capital and paid-up capital of Eris Formulations Private Limited?
The authorized share capital of Eris Formulations Private Limited is ₹ 10.00 Cr and paid-up capital is ₹ 2.00 M.
Who are the current board members & directors of Eris Formulations Private Limited?
Currently 2 directors are associated with Eris Formulations Private Limited.
- Amit Indubhushan Bakshi
- Himanshu Jayantbhai Shah
What is the registered address of Eris Formulations Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Eris Formulations Private Limited is 01 Amrakadam Co. Op. Housing Society Opp. Shukan Flats Ramdevnagar, Satellit India, Ahmedabad, Gujarat, 380015.
What is the corporate identification number (CIN) and company number of Eris Formulations Private Limited?
The corporate identification number (CIN) of Eris Formulations Private Limited is U24239GJ2012PTC069999 and the company number is 069999 as per Ministry of Corporate Affairs (MCA).
What is the official website of Eris Formulations Private Limited?
The Official website of Eris Formulations Private Limited is https://www.erislifesciences.com
When was the last Balance Sheet of Eris Formulations Private Limited filed with the ROC?
The most recent Balance Sheet for Eris Formulations Private Limited was filed with the ROC on 31 Mar 2015.